While colorectal cancer incidence has gone down among older people, incidence rates have steadily increased for people under age 50. Younger people are more likely to be diagnosed at a later stage and have unique challenges that come with facing cancer in their prime.

by Erin O’Donnell

Researchers are striving to understand why men are more likely than women to get and die from many types of cancer.

by Charlotte Huff

Forward Look

Study results show stereotactic body radiation therapy could be added to standard care.

by Carolyn Bernhardt

Forward Look

Protein signatures in the blood could help guide physicians in choosing among different immunotherapy drugs.

by Anna Napolitano

Forward Look

Physicians consider which patients are ideal for immunotherapy drug combinations.

by Leah Lawrence

From the Editor-in-Chief

Theranostics offers the promise of combining diagnosis and treatment.

by William G. Nelson, MD, PhD

Forum discusses next-generation technologies that will guide oncology research and patient care in the years to come.

by Thomas Celona

A study found women in California were more likely to have cervical cancer diagnoses at a later stage after age 65.

by Jon Kelvey

Immunotherapy before surgery is proving to be an effective treatment against melanoma.

by Sandra Gordon

Cologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.

by Jon Kelvey